A National Institutes of Health-backed study shows weekly injectable buprenorphine improves opioid abstinence and reduces serious risks compared to sublingual treatment in pregnant women with opioid use disorder.
National Institutes Of Health | 18/03/2026 | By News Bureau
National Institutes of Health Develops AI Tool to Predict Risk of Intimate Partner Violence
Researchers funded by National Institutes of Health have developed an AI-based clinical decision tool that predicts risk of Intimate Partner Violence using routine healthcare data with high accuracy.
National Institutes Of Health | 17/03/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy